Growth Metrics

Novartis Ag (NVS) Inventory (2016 - 2026)

Novartis Ag's Inventory history spans 15 years, with the latest figure at -$787.0 million for Q1 2026.

  • On a quarterly basis, Inventory changed N/A to -$787.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$787.0 million, a N/A change, with the full-year FY2025 number at $6.3 billion, up 987.96% from a year prior.
  • Inventory hit -$787.0 million in Q1 2026 for Novartis Ag, down from $6.3 billion in the prior quarter.
  • Over the last five years, Inventory for NVS hit a ceiling of $25.3 billion in Q2 2022 and a floor of -$787.0 million in Q1 2026.
  • Historically, Inventory has averaged $5.3 billion across 5 years, with a median of $5.8 billion in 2023.
  • Biggest five-year swings in Inventory: crashed 111.94% in 2024 and later skyrocketed 987.96% in 2025.
  • Tracing NVS's Inventory over 5 years: stood at $7.2 billion in 2022, then dropped by 17.59% to $5.9 billion in 2023, then crashed by 111.94% to -$706.0 million in 2024, then skyrocketed by 987.96% to $6.3 billion in 2025, then tumbled by 112.55% to -$787.0 million in 2026.
  • Business Quant data shows Inventory for NVS at -$787.0 million in Q1 2026, $6.3 billion in Q4 2025, and $10.0 million in Q3 2025.